Intellectual Property
Minneapolis/St. Paul
Trade Names vs Trademarks
Post-Grant Proceedings and Patent Enforcement
Qualifying for a Patent
Why Are Biologicals so Important?
Specimen
Convergence Density
IP Registration Density
Naming Problems with BioSimilars
What is a Trademark?
Intent of Patent Laws
Types of Intellectual Property Protection
Technical Background
Broad Patent Claim
Renewing a Trademark Registration
Effective Stay Strategy
Consequences of Disclosing Confidential Information
Circle "R"
Raising Good Prosecution Visibility
Risks of OSS
Merely Descriptive Refusal
How is the Entire Patent Considered Prior Art?
Seeking Money from Investors
Background
Date of First Use
Importance of Post-Grant Proceedings
Ideal Patent Strategy
Steps to Obtaining a Patent
Signing an NDA
Unlicensed Source Codes
Proper Way to Use a Trademark
Rewards of the Practice
Confidential Information
Independent Claim vs Dependent Claim
Value Management and Cash Flow
Rebutting a Merely Descriptive Refusal
Biologics vs Small Molecules
Practicing an Invention
Patent Citation Ranking
FDA Guidelines for Demonstrating Biosimilarity
Value Management Lifecycle
How do Patent Prosecution Services Vary in Value?
Geographic Insight and Patent Profile Analytics
Portfolio Mapping
Are BioSimilars Being Approved in the US?
Researching Competitors' IP
Importance of Freedom To Operate
Assessing Executive Experience
"Who" - Audit Action Sheet
Impact of US Hatch Waxman Act 1984
Secondary Meaning of a Trademark
Becoming a Patent Lawyer
Patent Analytics and Competition
How is Open Source Software Enforced?
Trade Secrets
How is Schwegman Lundberg & Woessner Different?
Experience
Patent Trial and Appeal Board
How Should IP be Considered for Acquisition?
PTAB Final Argument Trial Dynamics
Provisional Patent
Why Perform Risk Profile?
"Wheres" - Audit Action Sheet
Prior Art and Rejections
When to Do a Freedom to Operate
When is a House like a Patent?
"TM" Symbol
What Does an Audit Action Sheet Look Like?
Patent Status Updates
Limited Valuable Patents in Technology Area
Freedom To Operate vs Clearance
Provisional vs Non-Provisional Patent
Litigation and BioSimilar Patenting
How Do Patent Portfolio Values Become Concentrated over Time?
Consequences of a Poorly Drafted Patent
Considerations Before Hiring IP Council
Litigation Density
Inventorship
Patent Examination Process
Advantages of Registering a Trademark
What Should a Company Patent?
Post-Grant Options
High Risk Joint Ventures
Hard Assets
Repeating Competitor Audits
Downside of Static Budget Allocation for Patents
Challenges When Dealing with Patent Matters
What is a Patent Portfolio?
Most Common Client Question
Tracking Work History
Merrifield Synthesis
Am I Required to Search for Prior Art?
Attributes of a Good Patent
Trade Name Protection and Trademark Protection
How Does the Knowledge Gap Develop?
How can OSS Negatively Affect a Company?
Picking a Trademark
Importance of Getting a Patent
What Makes Schwegman, Lundberg & Woessner Different?
Open Source Initiative
Is There Still a Place for Traditional Re-Examination?
Joint Venture and Financial Agreements
How Big Should My First Patent Be?
How Much Does it Cost to Get a Patent?
The Advantage of Filing First
Post-Grant Options and Estoppel
Helping In-House Council
Demonstrating BioSimilarity Under U.S. Law
Freedom To Operate
Standard for Getting a Patent
Infringement on the Rights of Other Patents
Requirements to Receive a Patent
Segmenting a Portfolio
Attorneys and Patent Profile Analytics
Reasons to Consider Joint Ventures
Managing OSS
First Item on IP To-Do List
Interpretational Differences Between Prosecution and Litigation
How Long Does an FTO Take?
Using Product Association with IP Assets
Who Determines Substitution Factors?
Important Attributes to Being a Successful Patent Lawyer
Post-Grant Options and Cost
Inter Partes Review
The Five Components of an Open Source Software Policy
What is a BioSimilar Product Under US Law?
NDAs and Customers
What Engineers Can Learn from Patent Profile Analytics
Intellectual Property Protection
Patent Profile Analytics and Managers
What is Prior Art?
Common Reasons Trademarks Are Rejected
Limiting Issues Defined in District Court
Factors That Cause a Patent to Decline in Value
Joint Venture Pitfalls
Freedom to Operate (FTO) Process
Open Source Software
Copyright
Mitigating Risks of Past Damages
Common Law Trademark Rights
How Should IP be Considered for Growth?
Backward Citations
Impact of Post-Grant Proceedings
Value Management and Risk Management
Traditional Re-Examination
Trademarks and Brand Value
Discovering Annuity Information
Third Party Confidentiality
Post-Grant Options and Grounds of Challenge
Tools for Auditing a Patent Portfolio
Patent Strategy Considerations
OSS Licensing Conditions
Genericide
Refused Trademark Recourse
Biologics Price Competition and Innovation Act
Patent Ownership and Patent Profile Analytics
Office Action
Meet David Black
Post-Litigation Challenges
Risks of Not Patenting
Auction Audit Sheet - Key Issues to Address
Marking a Product
Sponsor
What is a Patent?
Low Risk Joint Ventures
Cited Art Landscape
ITU
Inventors and Patent Analytics
What Doesn't a Patent Provide?
BioSimilar Patenting Litigation Involving Large Amounts of Money
Calculating New Investments
Post-Grant Proceedings
Should IP be Part of Our Business Plan?
Process for Registering a Trademark in the United States
Equal Value Patents
Moderate Risk Joint Ventures
Wasting Money on Low-Value Patents
Claim Maps and BioSimilars
Freedom to Operate
Patent Profile Analytics and Engineers
How to Remedy Unwanted Disclosure of Confidential Information
Domain Registration Considerations
Infringing on Another Patent
Licensing Density
How Does the Knowledge Gap Worsen Over Time?
Patents 101
Pre-Litigation Challenges
Risk Profile
Soft Assets
"Whens" - Audit Action Sheet
Purposes of a Trademark
Joint Venture Ground Rules
4 Ways to Prepare your Patent Portfolio for Battle.
Audit Action Sheet
Evaluation Agreement and Computer Codes
What is a BioSimilar?
Patent Portfolio and Budgets/Spending
"Whats" - Audit Action Sheet
Contractual Intellectual Property Rights
Picking a Domain Name
Trade Dress
Prior Art in Prosecution vs Prior Art in Litigation
Unanticipated OSS
What Should a Company Understand at the End of an IP Audit?
Improving Patent Portfolio Value
"SM" Symbol
How to Fix the Knowledge Gap
The Case of the Joint Marketing Agreement Gone Bad
Attorneys Not Understanding the Market
"Claims" of a Patent
Why Should Claims Not Be Read on the Prior Art?
Meet Mark Stignani
Patents and Other Forms of Intellectual Property Protection
Value-Driven Patent Portfolio
Portfolio Dashboard - Inventor Information
Schwegman Lundberg & Woessner & Post Grant Trial Practice
What to Do When First Selecting a Mark
By the Numbers Overview
PTAB Timing Trial Dynamics
Inventorship vs Ownership
Get Your Assignments Straight - Contribution of Owners
Post-Grant Review
Cost of Registering a Trademark
Confidential Information and Business Damage
Golden Rule of Auditing a Patent Portfolio
How is Open Source Incorporated into Software?
Different Parts of a Patent Document
Factors That Make a Patent Valuable
Improperly Marked Product
Schwegman, Lundberg & Woessner - Chemicals and Pharmaceuticals
The Different Types of Marks
Hiring Patent Council
What IP Should I Spend Money on First?
Non-Disclosure Agreement
Impact of PTAB
Implementing a Value-Driven Portfolio Process
Trademark
Patent Infringement
Claim Abstraction Theory
Prior Art Challenge
Establishing Confidentiality
Trademark Filing Considerations
A Better Way to Allocate Patent Application Budgets
Why Do You Enjoy Being a Lawyer?
Preventing "Genericide"
How to Navigate BioSimilar Challenges
"How Much" - Audit Action Sheet
Is A United States Registered Trademark Effective in Other Countries?
Covered Business Method Review
Goal of a Value-Driven Patent Portfolio
NDAs and Computer Codes
Forms of Confidential Information
A Less Expensive Alternative
Outside of Law
Why Is Executing an NDA Not Enough?
Joint Ventures and Dispute Resolution
Benefits of Audit Action Sheet
5 Year View Point
Patents and Practicing an Invention
Engineers Not Understanding Patents
Scope Concepts and Headnotes
Patent Owner Rights
What Do I Give up in Getting My Patent?
Determining Likelihood of Confusion
What is an Invention?
Approvals of BioSimilars in Europe
First Step in Performing a Patent Portfolio Audit
Patent Profile Analytics and Researchers
Categories of Marks
Types of Inventions That Are Patentable
Cost/Value Curve of Patent a Portfolio
Do Narrow Patents Add Value to a Portfolio?
Budgeting for Drafting and Prosecution
Cost/Value Curve of a High Level Patent
Forward Citation Landscape
Two Main Value Drivers